IPTi Consortium

BARCELONA, Spain - - The Lancet Publishes New Findings Showing 30% Reduction in Babies Under 12 Months Using a WHO-Recommended Approach, but few African Countries Have Adopted it A third (30%) of malaria cases can be avoided in African infants using a safe, affordable and simple tool called Intermittent Preventive Treatment of malaria in Infants (IPTi) with the medicine sulphadoxine-pyrimethamine (SP), which can be delivered alongside existing childhood vaccination programmes.(i) Results of a meta-analysis examining six clinical trials in Africa for the malaria intervention which the World Health Organization already recommends are published online today in the medical journal, The Lancet.